TREX1 mutations are not associated with sporadic inclusion body myositis

Autor: Fieke M.E. Cox, Jan J.G.M. Verschuuren, Umesh A. Badrising, Egbert Bakker, E. M. J. Boon, C. A. C. Van Der Lans
Přispěvatelé: Human genetics
Jazyk: angličtina
Rok vydání: 2010
Předmět:
Zdroj: European Journal of Neurology, 17(8), 1108-1109
European Journal of Neurology, 17(8), 1108-1109. Wiley-Blackwell
Cox, F M, Boon, E M J, Van Der Lans, C A C, Bakker, E, Verschuuren, J J G M & Badrising, U A 2010, ' TREX1 mutations are not associated with sporadic inclusion body myositis ', European Journal of Neurology, vol. 17, no. 8, pp. 1108-1109 . https://doi.org/10.1111/j.1468-1331.2010.02964.x
ISSN: 1351-5101
DOI: 10.1111/j.1468-1331.2010.02964.x
Popis: Background: Sporadic inclusion body myositis (sIBM) is the most frequent acquired myopathy above the age of fifty. The exact mechanism causing this disease is not known, but immune-mediated features are prominent and are probably to play a role in its pathogenesis. TREX1 gene mutations are associated with a large range of autoimmune diseases, such as systemic lupus erythematosus. We investigated whether mutations in the TREX1 gene were associated with sIBM. Methods: Fifty-four patients with sIBM were tested for TREX1 mutations by direct sequencing. Results: All 54 patients tested negative for pathogenic mutations in the TREX1 gene. One presumed non-pathogenic polymorphism was found in 42 out of 54 patients. Conclusion: TREX1 mutations do not play a role in the pathogenesis of sIBM.
Databáze: OpenAIRE